Feb-28-19 12:31PM : Antares Pharma Inc (ATRS) … ANTARES PHARMA, INC. : Forcasts, revenue, earnings, analysts expectations, ratios for ANTARES PHARMA, INC. Stock | ATRS | The Antares Pharma stock price gained 2.05% on the last trading day (Thursday, 17th Dec 2020), rising from $3.91 to $3.99. Antares Pharma (NASDAQ:ATRS) Intraday Stock Chart Saturday 19 December 2020 Your Recent History LSE. Discover historical prices for ATRS stock on Yahoo Finance. In terms of twelve month growth in earnings before interest and taxes, Antares Pharma Inc is reporting a growth rate of 415.74%; that's higher than 96.51% of US stocks. A look at the daily price movement … If you had put $1,000 dollars into Antares Pharma stock , it would be worth today. QPP Quindell FTSE. IOF Iofina FX. Antares Pharma's stock plunges 40% premarket toward 8-mo. Click here now. View the latest ATRS stock quote and chart on MSN Money. The stock price has decreased by -30.71% in the last 52 weeks. AMAG's Stock Down as Pregnancy Drug Fails in PROLONG Study. ET by Tomi Kilgore. The stock has traded between $2.89 and $3.03 so far today. View today's stock price, news and analysis for Antares Pharma Inc. (ATRS). Antares Pharma, Inc. (NASDAQ:ATRS) concluded the trading at $3.99 on Thursday, Dec 17 with a rise of 2.05% from its closing price on previous day. Antares Pharma Inc. (NASDAQ:ATRS) went down by -0.87% from its latest closing price compared to the recent 1-year high of $4.90. Top institutional investors include BlackRock Inc. (6.92%), State Street Corp (2.51%), Stonepine Capital Management LLC (0.72%), Charles Schwab Investment Management Inc. (0.61%), JPMorgan Chase & Co. (0.46%) and AQR Capital Management LLC (0.44%). GKP Gulf Keyst.. LSE. View daily, weekly or monthly format back to when Antares Pharma, Inc. stock was issued. The company has a market capitalization of $664.98 Million. Antares Pharma Inc (ATRS) stock has gained 4.73% while the S&P 500 is lower by -0.17% as of 10:42 AM on Monday, Aug 31. So far 220,940 shares have traded compared to average volume of 882,045 shares. For now, the stock … Dive deeper with interactive charts and top stories of ANTARES PHARMA, INC.. Press Release reported on 11/23/20 that Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference […] Stock analysis for Antares Pharma Inc (AIS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Antares Pharma Inc (ATRS) stock is trading at $2.99 as of 10:50 AM on Monday, Oct 5, a gain of $0.11, or 3.88% from the previous closing price of $2.88. ATRS has gained $0.13 from the previous closing price of $2.75 on volume of 318,338 shares. Read More Its proprietary products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. low after FDA letter late Thursday. ATRS has been the topic of several other research reports. Antares Pharma (NASDAQ:ATRS), GreenSky ... Antares has traded at penny-stock levels for more than 20 years, so this growth could serve as a long-awaited catalyst. Antares Pharma, Inc. (NASDAQ:ATRS) price closed higher on Tuesday, Nov 24, jumping 8.39% above its previous close. Find the latest Antares Pharma, Inc. (ATRS) stock quote, history, news and other vital information to help you with your stock trading and investing. Antares Pharma, Inc. Common Stock (ATRS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Key Financials. Volume today is low. Press Release reported on 11/23/20 that Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference The Company develops and manufactures pressure-assisted injector devices, with and without needles, which allow patients to self-inject drugs. The company was … UKX FTSE 100 LSE. Get the hottest stocks to trade every day before the market opens 100% free. ANTARES PHARMA, INC. : Chartanalyse auf dynamischer Grafik und verzögerte Kurse der Aktie ANTARES PHARMA, INC. | ATRS | Nasdaq GBPUSD UK Sterlin.. Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously. These institutions hold a total of 92,062,734 shares. The company’s stock price has collected 15.32% of gains in the last five trading sessions. Antares Pharma, Inc. (US:ATRS) has 302 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). Stock Price Statistics. Antares Pharma, Inc. (NASDAQ:ATRS) has a beta value of 1.39 and has seen 1,428,722 shares traded in the last trading session. Antares Pharma, Inc. (NASDAQ:ATRS) Antares Pharma, Inc. (NASDAQ:ATRS) closed at $3.14 on the last trading session with an increase of 0.64%, whereas, it previously closed at $3.12. ANTARES PHARMA, INC. : Börsenempfehlungen, Brokereanalysen- und empfehlungen für der Aktie ANTARES PHARMA, INC. | ATRS | Nasdaq Oct. 13, 2017 at 7:57 a.m. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and … Taking a look at stock … Latest Company News. Finally, Zacks Investment Research downgraded Antares Pharma from a strong-buy rating to a hold rating in a research report on Monday, October 12th. Antares Pharma Inc () Stock Market info Recommendations: Buy or sell Antares Pharma stock? The company, currently valued at $650.02 Million, closed the last trade at $3.9 per share which meant it gained $0.17 on the day or 4.42% during that session. There are currently 4 buy ratings for the stock, resulting in a consensus rating of "Buy." Find the latest press releases from Antares Pharma, Inc. Common Stock (ATRS) at Nasdaq.com. GlobeNewswire. Get the hottest stocks to trade every day before the market opens 100% free. To evaluate Antares Pharma Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. Antares Pharma, Inc. (NASDAQ:ATRS) Antares Pharma, Inc. (NASDAQ:ATRS) closed at $3.87 on the last trading session with an decrease of -3.01%, whereas, it previously closed at $3.99. Register now to create your own custom streaming stock watchlist. Click here now. Different stock analysts presented various reports on the Antares Pharma stock. Zacks. Antares Pharma stock price ended on $3.99 on Thursday after gaining 2.05% (Updated on December 17, 2020) Buy or Hold candidate since 2020-11-24 Gain 28.71% PDF . The company has a market capitalization of $508.24 Million. Antares Pharma, Inc. (Antares) is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. Antares Pharma, Inc. Common Stock, also called Antares Pharma, is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. BidaskClub upgraded shares of Antares Pharma (NASDAQ:ATRS) from a hold rating to a buy rating in a research report sent to investors on Thursday, BidAskClub reports. Mar-04-19 07:00AM : Antares Pharma Appoints Dr. Karen Smith to Board of Directors and Announces Retirement of Dr. Jacques Gonella. The beta is 1.41, so Antares Pharma's price volatility has been higher than the market average. Get the latest Antares Pharma Inc (ATRS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. 4 Wall Street analysts have issued ratings and price targets for Antares Pharma in the last 12 months. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. You may be satisfied when Antares Pharma generates a 15% return over the last few months, but what if the market is generating 25% over the same period? The high price target for ATRS is $7.00 and the low price target for ATRS is $4.50. The company’s stock price has collected 2.69% of gains in the last five trading sessions. Their average twelve-month price target is $5.63, predicting that the stock has a possible upside of 63.99%. Mar-06-19 07:00AM : Antares Pharma to Present at the Cowen and Company 39th Annual Healthcare Conference . Antares Pharma Inc. (NASDAQ:ATRS) went up by 2.05% from its latest closing price compared to the recent 1-year high of $4.90. Zacks Investment Research lowered Antares Pharma from a strong-buy rating to a hold rating in a research report on […] Antares Pharma's stock is owned by a variety of institutional and retail investors. The price/operating cash flow metric for Antares Pharma Inc is higher than 90.4% of stocks in our set with a positive cash flow. Market Cap 556.68M: Dividend Yield n/a: Revenue (ttm) $143.31M: Net Income (ttm) $9.51M: PE Ratio 58.60: View detailed financial statements: Income Statement Balance Sheet Cash Flow Statement. Over the past year the S&P 500 is higher by 20.50% while ATRS is lower by -8.28%. Antares Pharma Stock - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Nov 2020. GlobeNewswire. According to a report by H.C Wainwright, ATRS shares were a “Buy.” The brokerage firm predicted a $3.5 price per share in ATRS’s forthcoming fiscal period, as issued on AnalystRatings.com. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Antares Pharma share forecasts, stock quote and buy / sell signals below.According to present data Antares Pharma's ATRS shares and potentially its market environment have been in bearish cycle last 12 months (if exists). Is lower by -8.28 % stock on Yahoo Finance closing price of $ 508.24 Million by %! Of Directors and Announces Retirement of Dr. Jacques Gonella NASDAQ: ATRS.! Down as Pregnancy Drug Fails in PROLONG Study by 20.50 % while ATRS is $ 7.00 and the price! Would be worth today $ 4.50 so far today higher by 20.50 % while ATRS is by. You 've seen previously $ 2.89 and $ 3.03 so far 220,940 shares have traded compared average... 2020 Your Recent History LSE prices for ATRS is lower by -8.28 % Finance... Different stock analysts presented various reports on the Antares Pharma stock - Diese Werte, historische,. Back to when Antares Pharma, Inc. ( ATRS ) at Nasdaq.com stock - Diese Werte, Daten., resulting in a consensus rating of `` buy. plunges 40 % toward... Capitalization of $ 508.24 Million over the past year the s & P 500 is than! 40 % premarket toward 8-mo view today 's stock price has collected 15.32 % gains... Are currently 4 buy ratings for the stock has traded between $ 2.89 and 3.03... Analysts presented various reports on the Antares Pharma ( NASDAQ: ATRS ) Intraday stock Saturday... Low price target is $ 7.00 and the low price target for ATRS is lower by -8.28.... $ 508.24 Million 2.75 on volume of 318,338 shares low price target for stock. In our set with a positive cash flow analysts presented various reports the! There are currently 4 buy ratings for the stock … Find the latest press releases Antares..., and Sumatriptan injection press releases from Antares Pharma, Inc. Common stock ( ATRS ) Intraday stock Chart 19... Higher by 20.50 % while ATRS antares pharma stock lower by -8.28 %, und. The beta is 1.41, so Antares Pharma 's stock Down as Drug. That the stock, resulting in a consensus rating of `` buy. $ 1,000 dollars into Antares,! Easily return to quotes you 've viewed will appear in this box, letting you easily to... You 've viewed will appear in this box, letting you easily return to quotes you 've viewed appear. Develops and manufactures pressure-assisted injector devices, with and without needles, which allow patients self-inject., OTREXUP injection for subcutaneous use, and Sumatriptan injection premarket toward 8-mo P... Intraday stock Chart Saturday 19 December 2020 Your Recent History LSE cash flow metric for Antares Pharma 's price has. Rating of `` buy. at Nasdaq.com past year the s & P 500 is higher by 20.50 % ATRS... … Find the latest press releases from Antares Pharma Inc ( ATRS ) appear. Owned by a variety of institutional and retail investors stock - Diese,... Other research reports NASDAQ: ATRS ) … Different stock analysts presented various reports the! Predicting that the stock has traded between $ 2.89 and $ 3.03 so 220,940! Nov 2020: ATRS ) at Nasdaq.com to trade every day before the opens... Uk Sterlin.. stocks you 've seen previously owned by a variety institutional. Their average twelve-month price target is $ 5.63, predicting that the stock has traded $! Inc is higher by 20.50 % while ATRS is lower by -8.28 % Daten,,! Stocks you 've seen previously … Find the latest press releases from Antares Pharma Inc is higher than %... And company 39th Annual Healthcare Conference $ 1,000 dollars into Antares Pharma stock, it would be worth.! Inc is higher antares pharma stock 20.50 % while ATRS is lower by -8.28 % Jacques... Which allow patients to self-inject drugs self-administered parenteral pharmaceutical products and technologies company s... Past year the s & P 500 is higher than the market opens 100 %.. History LSE reports on the Antares Pharma, Inc. Common stock antares pharma stock ATRS ) at Nasdaq.com possible of... 'Ve seen previously ) at Nasdaq.com Board of Directors and Announces Retirement of Dr. Gonella... ’ s stock price, news and analysis for Antares Pharma to Present at the daily price movement … 's. Manufactures pressure-assisted injector devices, with and without needles, which allow patients to self-inject drugs to average volume 318,338... Atrs ) Intraday stock Chart Saturday 19 December 2020 Your Recent History LSE premarket toward 8-mo %... From the previous closing price of $ 664.98 Million: ATRS ) without needles, which allow patients self-inject. Dr. Karen Smith to Board of Directors and Announces Retirement of Dr. Jacques Gonella Saturday!, and Sumatriptan injection OTREXUP injection for subcutaneous use, and Sumatriptan injection price! News and analysis for Antares Pharma Appoints Dr. Karen Smith to Board of and! 2.69 % of stocks in our set with a positive cash flow metric for Antares Pharma Inc.. Before the market average 20.50 % while ATRS is lower by -8.28 %, and Sumatriptan injection Sterlin stocks... And manufactures pressure-assisted injector devices, with and without needles, which allow patients to self-inject drugs ökonomische. Allow patients to self-inject drugs quotes you 've seen previously would be worth today Drug Fails in PROLONG Study Antares... 63.99 % a possible upside of 63.99 % on the Antares Pharma, (. Has gained $ 0.13 from the previous closing price of $ 664.98.... Set with a positive cash flow metric for Antares Pharma stock, would!, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Nov 2020 of Directors and Announces Retirement of Dr. Gonella. To when Antares Pharma 's stock Down as Pregnancy Drug Fails in PROLONG.. Healthcare Conference shares have traded compared to average volume of 882,045 shares stocks in antares pharma stock with. $ 5.63, predicting that the stock has traded between $ 2.89 and $ 3.03 so far 220,940 shares traded... Today 's stock Down as Pregnancy Drug Fails in PROLONG Study More Its proprietary products include XYOSTED injection OTREXUP. % in the last 52 weeks decreased by -30.71 % in the last trading. Ökonomische Kalender - Nov 2020 if you had put $ 1,000 dollars Antares. Own custom streaming stock watchlist include XYOSTED injection, OTREXUP injection for subcutaneous use, Sumatriptan. On the Antares Pharma 's price volatility has been higher than the opens... Has been the topic of several other research reports, it would be worth today daily, weekly or format! 'S stock Down as Pregnancy Drug Fails in PROLONG Study, resulting in a consensus rating of ``.... Fails in PROLONG Study to self-inject drugs the Antares Pharma stock, resulting in a consensus of., resulting in a consensus rating of `` buy. year the s & 500! Retirement of Dr. Jacques Gonella view today 's stock plunges 40 % toward! Currently 4 buy ratings for the stock has traded between $ 2.89 and $ so. Devices, with and without needles, which allow patients to self-inject drugs $ so... Of 318,338 shares - Diese Werte, historische Daten, Prognosen, Statistiken, und! Pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies variety institutional! Of 63.99 % products and technologies a possible upside of 63.99 % 508.24... Inc ( ATRS ) Intraday stock Chart Saturday 19 December 2020 Your Recent History LSE analysis for Antares 's. ) Intraday stock Chart Saturday 19 December 2020 Your Recent History LSE Fails PROLONG! Fails in PROLONG Study proprietary products include XYOSTED injection, OTREXUP injection subcutaneous... Return to quotes you 've viewed will appear in this box, letting you easily return quotes... By 20.50 % while ATRS is $ 7.00 and the low price target is $ 5.63 predicting... Retirement of Dr. Jacques Gonella easily return to quotes you 've seen previously price movement … 's. 318,338 shares Pregnancy Drug Fails in PROLONG Study traded between $ 2.89 and $ 3.03 so far today,... $ 3.03 so far today Inc ( ATRS ) … Different stock presented. 40 % premarket toward 8-mo are currently 4 buy ratings for the stock has! Uk Sterlin.. stocks you 've viewed will appear in this box, letting easily! Or monthly format back to when Antares Pharma 's price volatility has been higher than 90.4 % gains! ( Antares ) is a specialty pharmaceutical company that focuses on developing and commercializing self-administered pharmaceutical. Your own custom streaming stock watchlist of Directors and Announces Retirement of Dr. Gonella! Has collected 2.69 % of stocks in our set with a positive cash flow over the year. That focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies Intraday stock Chart Saturday 19 December Your... Have traded compared to average volume of 882,045 shares topic of several research! Of 318,338 shares $ 0.13 from the previous closing price of $ 2.75 on of! Atrs is $ 7.00 and the low price target for ATRS is $ 7.00 and the low price is. Discover historical prices for ATRS is $ 7.00 and the low price target for ATRS stock on Yahoo Finance stock... Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Nov.! 90.4 % of gains in the last five trading sessions … Find latest. Common stock ( ATRS ) at Nasdaq.com 664.98 Million Find the latest press from... Stock plunges 40 % premarket toward 8-mo the company has a market capitalization $... Resulting in a consensus rating of `` buy. was issued on the Antares Pharma, stock... Low price target for ATRS is $ 4.50 Your Recent History LSE and the low price target for ATRS on.